Recent Articles

• Boston International Holdings Reports Loss and Strategy Shift
• Åsa Thunman's Departure from Sandvik and Future Plans
• European Companies Trim Workforce Amid Economic Challenges
• Major Brokerages Anticipate Steady Rates at Fed's Upcoming Meeting
• Record Growth in Concierge Medicine: Specialdocs Expands Network
• Cmbio® Expands Its Digital Biology Platform with Key Acquisition
• Supreme Court's Critical Decision on TikTok Ban Looms Ahead
• Intellia Therapeutics Implements Strategic Changes to Focus Growth
• Piper Sandler Boosts Nike's Rating and Price Target Significantly
• Constellation Energy's Game-Changing Acquisition of Calpine
• China Evergrande Ordered to Repay $1.8 Billion Deposit Pledges
• UBS Downgrades Tele2 to 'Sell' Amid Concerns Over Growth
• Toll Brothers Sees Growth Amid Los Angeles Wildfire Crisis
• Scottie Pippen's Stark Warning on Bitcoin's Future Trap
• ZenaTech's ZenaDrone Aims for FAA Certification in Agriculture
• Royalty Pharma's Strategic Growth and Future Prospects Unveiled
• Vikram Kapoor Joins Golconda Gold Ltd. Board as Director
• Unlocking Drug Discovery: Absci Partners with Owkin for Innovation
• Churchill Downs Inc. Plans Q4 2024 Financial Results Call
• Ranchero Gold Corp. Finalizes Debt Settlement Process Successfully
• Tourmaline Bio Appoints Dr. Paul M. Ridker to Advisory Board
• Prairie Operating Co. Advances with Shelduck South Pad Success
• Strategic Merger Between CNB Financial and ESSA Bancorp Set to Enhance Services
• Constellation Brands Showcases Impressive Q3 Fiscal Results
• Y-mAbs Welcomes Doug Gentilcore as DANYELZA Leader
• Understanding the Shift in Norges Bank's Shareholding in NKT
• Zai Lab and Vertex Join Forces to Bring Povetacicept to Asia
• Vertex and Zai Lab Enter Strategic Agreement for Pove Development
• Nektar Therapeutics Reaches Key Milestone in AD Trial Success
• Royalty Pharma's Strategic Maneuvers: Aiming for Growth and Efficiency
• Xeris Biopharma Projects Strong Revenue Growth for 2024
• Lazard Strengthens Team with New Global Head of Sports Advisory
• Baronsmead Venture Trust Unveils Major Share Subscription Offer
• GH Research Achieves Milestones in Groundbreaking Depression Trials
• Bio-Path's Ambitious 2025 Goals in Cancer and Diabetes Research
• Lantronix Welcomes Brent Stringham as New CFO Amid Growth
• Spero Therapeutics Transitions Leadership Amid Regulatory Scrutiny
• Arvinas Inc. Unveils Strategic Plans for 2025 Clinical Trials
• Baronsmead VCTs Unveil New £50 Million Investment Opportunity
• Opera Limited to Showcase Insights at Growth Conference
• Royalty Pharma's Bold Moves: Acquisition and Buyback Insights
• Net Lease Office Properties Reports Significant Asset Sales
• Alphyn Biologics Shows Promising Advances in Skin Health
• Spectral Capital Announces Aaron Christensen as New CRO
• Walgreens Boots Alliance Reports Strong Q1 Performance Insights
• Analysts Warn of Potential Economic Challenges Ahead
• Insurance Sector Faces Turmoil Due to Rising Wildfire Losses
• Walgreens Boots Alliance Achieves Profit Surprises Amidst Revamp
• Insights on 2025 EPS Growth Projections Across S&P 500
• Gulf Investments in the U.S. Expected to Surge with Leadership Change